BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES
BAFITEA
![Foto de BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES](/img/grupo.png)
![Foto de Radboud University Nijmegen Medical Centre](/img/noimage_org.png)
Radboud University Nijmegen Medical Centre
Nimega, HolandaRadboud University Nijmegen Medical Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (32)
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029
-
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607
-
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes
Clinical and Experimental Rheumatology
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
2012
-
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
Arthritis Research and Therapy, Vol. 14, Núm. 2
-
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 6, pp. 458-460
-
Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up
Human Molecular Genetics, Vol. 21, Núm. 12, pp. 2825-2835
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
-
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118
-
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196
2011
-
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 638-641
-
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 454-462